Structural and Functional Analyses of Retinal Ischemia in Eyes with Retinal Vein Occlusion: Relationship with Macular Edema or Microaneurysm Formation by Taneto Tomiyasu et al.
Nagoya City University Academic Repository
Structural and Functional Analyses of Retinal Ischemia in Eyes with Retinal Vein 
Occlusion: Relationship with Macular Edema or Microaneurysm Formation
Taneto Tomiyasu, Yoshio Hirano, Norihiro Suzuki, Yuya Esaki, Yusuke Yasuda, 
Akiyoshi Uemura, Tsutomu Yasukawa, Munenori Yoshida, Yuichiro Ogura
Opthalmic Research  61(4): 218 - 225
2019-04
@2018 S.karger AG, This is the accepted manuscript version of the article. The formal 








ORE493489 - Ophthalmic Res - ISSN 0030–3747 (for internal use only) 
Code 3 PE CE Copy edited Figures Tables Suppl. mat. Typesetting 
ORE gs oc 8.10.18 4 2  bk 




 Template_Art ZU 
 











Queries to the author 1. Please confirm that authors' names and initials have been identified 
correctly. 
2. Table 2: please explain ** ■■■. 




Article title Structural and Functional Analyses of Retinal Ischemia in Eyes with Retinal 
Vein Occlusion: Relationship with Macular Edema or Microaneurysm 
Formation 
Article title second language  
Article title third language  
Subtitle  
Short title  Structural and Functional Analyses of Retinal Ischemia in RVO 













2367438 T. Taneto Tomiyasu  
2367439 Y. Yoshio Hirano  
2367440 N. Norihiro Suzuki  
2367441 Y. Yuya Esaki  
2367442 Y. Yusuke Yasuda  
2367443 A. Akiyoshi Uemura  
2367444 T. Tsutomu Yasukawa  
2367445 M. Munenori Yoshida  
2367446 Y. Yuichiro Ogura  
     
 
 
Affiliation(s) City State Country 
 Department of Ophthalmology and Visual Science, Nagoya City 
University Graduate School of Medical Sciences 
Nagoya  Japan 
     
     
     
 
 
Additional information Presented at the 71st Annual Congress of Japan Clinical Ophthalmology 
(Tokyo, Japan) on October 13th, 2017. 
 
 
Corresponding author Yoshio Hirano, MD, PhD 
Full address Department of Ophthalmology and Visual Science 
 Nagoya City University Graduate School of Medical Sciences 
 1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601 (Japan) 
E-Mail E-Mail yoshio.hirano@gmail.com 
 
 
Citation line Journal 
 Ophthalmic Res 
10.1159/000493489 Article-Nr 493489 CCCode  
ISSN 0030–3747  
ISBN    
 
Received Received: July 4, 2018 
Accepted Accepted after revision: September 3, 2018 
Revised  
Published online Published online: ■■■ 
Copyright statement © 2018 S. Karger AG, Basel 




 Optical coherence tomography angiography 
Retinal thickness 
Microperimetry 





Keywords Second Language  
  
 








Purpose: To study the structural and functional changes of retinal ischemia and investigate 
their association with macular edema (ME) or microaneurysm (MA) formation in eyes with 
retinal vein occlusion (RVO). Methods: Sixty eyes of 30 patients (27 eyes with branch [b]RVO, 
3 with central RVO, and 30 fellow eyes) were retrospectively reviewed. Optical coherence 
tomography (OCT), OCT angiography (OCTA), and microperimetry were performed 
simultaneously to measure retinal thickness and sensitivity. The presence of ME or MA was 
also assessed using OCT and fluorescein angiography. Results: The mean retinal sensitivity in 
the nonperfused areas (NPAs) deteriorated, and this was significantly (r = –0.379, p = 0.0391*) 
and inversely correlated with duration from disease onset. ME and MA were unlikely to be 
observed around the area where the retinal sensitivity decreased. In the NPAs, the mean retinal 
thickness of the superficial capillary plexus (SCP) (p < 0.0001), deep capillary plexus (DCP) (p = 
0.0323), and outer retina (p = 0.0008) were significantly thinner than those in the fellow eyes, 
respectively. Multivariate regression analysis revealed that the thicknesses of the DCP (β: 
0.3107, p = 0.0007) and outer retina (β: 0.3482, p = 0.0001) were the independent correlative 
factors of the retinal sensitivity, but that SCP thickness was not. Conclusion: Deep retinal 
thinning in NPAs was correlated significantly with a decreased retinal sensitivity, which might be 
a negative predictor of ME and MA in eyes with RVO. 
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Retinal vein occlusion (RVO) causes various retinal microangiopathies, one of which is 
retinal ischemia. Ischemia usually leads to hypoxia, followed by upregulation of vascular 
endothelial growth factor (VEGF). In fact, several reports have shown overexpression of VEGF 
in eyes with RVO [1, 2], which can lead to vision-threatening conditions such as macular edema 
(ME) [3], microaneurysm (MA) [4], and retinal neovascularization [3]. Therefore, investigation of 
retinal ischemia might be important when considering treatment for patients with RVO.  
Finkelstein [5] previously reported that ischemic ME is associated with good visual 
outcomes because the ME is often transient. In this report, however, only fundus examination 
and fluorescein angiography (FA) were used to assess retinal ischemia and ME. For example, 
nonperfused areas (NPAs) on FA images were defined as retinal ischemia and the presence of 
ME was confirmed based on these images and fundus examination. We recently reported that 
optical coherence tomography angiography (OCTA) is more useful to detect NPAs in eyes with 
branch (B)RVO than FA because OCTA is free from dye and provides higher-resolution images 
[6, 7]. For assessment of ME, OCT enables measurements of the thickness of the whole retina 
but also of each retinal layer. Moreover, only visual acuity (VA), which usually represents a 
central vision, was used for analysis of visual function in our previous study, while 
microperimetry enables assessment of fundus-correlated visual function with an eye tracker. 
Therefore, with OCT, OCTA, and microperimetry, it is possible to perform more detailed 
analyses of retinal ischemia, ME, and visual function, leading to a better understanding.  
Several reports [8, 9] have been published recently that evaluate the relationship 
between macular ischemia and visual function using OCT, OCTA, and microperimetry in eyes 
with RVO. However, the relationship between retinal ischemia and ME or MA was not examined, 
and the thickness of the entire retina was measured, not of each retinal layer. Moreover, retinal 
sensitivity was measured using MP-1 (Nidek, Gamagori, Japan), which limits the range of 
stimulus intensities to 0–20 dB. A recently developed microperimeter, MP-3 (Nidek), provides a 
wider range of stimulus intensities (0–34 dB) than the previous-generation MP-1, enabling a 
precise evaluation of visual function.  
In this study, we aimed to evaluate structural and functional analyses of retinal ischemia 
in eyes with RVO using multiple modalities including OCT, OCTA, and MP-3. The relationship 
with ME or MA formation was assessed to study the pathological significance of retinal ischemia 
in eyes with RVO. 
Methods 
Patients 
This was a retrospective, observational, and consecutive case series conducted at 
Nagoya City University (NCU) Hospital from August 2016 to October 2016. The NCU 
Institutional Review Board approved the study protocol (No. 60160087). The clinical trial was 
registered in UMIN-CTR (UMIN-ID: UMIN000025883). All experiments were performed in 
accordance with the Declaration of Helsinki. All patients provided written informed consent to 
participate in this study.  
Patients with eyes with ME after RVO, who completed MP-3 measurements, and who 
gave their consent for the study were included. Patients with other retinal diseases, poor-quality 
images, ME with a retinal thickness of >400 µm, serous retinal detachment, or without NPAs 
were excluded. 
All patients underwent ophthalmic examinations including measurement of best-corrected 
VA, axial length (IOL Master 500, Carl Zeiss, Dublin, CA, USA), indirect ophthalmoscopy, 
fundus photography, OCT (Cirrus HD-OCT, Carl Zeiss), OCTA (RS-3000 Advance, Nidek), 
microperimetry (MP-3, Nidek), FA/indocyanine green angiography (ICGA) using confocal 
scanning laser ophthalmoscopy (Heidelberg Retina Angiography 2, Heidelberg Engineering, 
Heidelberg, Germany), and wide-field FA/ICGA (Optos California, Optos, Dunfermline, Scotland, 
UK). All eyes were diagnosed and the subtype or perfusion status was determined using these 
multiple modalities.  
Evaluation of Retinal Ischemia Using Multiple Modalities 
MP-3 was used to measure retinal sensitivity as previously described [10]. Two 
experienced examiners performed all the tests. A custom-designed grid was used to examine 
33 stimulus locations covering central 5°, similar to 3 × 3 mm sections centered on the fovea 
(Fig. 1a, b). After completion of the test, fundus images with retinal sensitivity values (MP-3 
images) were transferred to the OCTA system. 
OCTA images were captured in 3 × 3 mm sections centered on the fovea as well (Fig. 
1c–e). The OCTA and MP-3 images were superimposed by matching retinal vessels on the 
OCTA system (Fig. 1g), enabling assessment of the retinal sensitivity in NPAs which was 
defined on OCTA images. The mean retinal sensitivity was compared among fellow eyes, 
perfused areas, and NPAs in RVO eyes. 
Retinal thicknesses were measured on OCTA at all MP-3 measurement points. They 
included the entire retina, from the internal limiting membrane (ILM) to the retinal pigment 
epithelium (RPE); the retinal superficial capillary plexus (SCP), from the ILM to the inner 
plexiform layer (IPL); the retinal deep capillary plexus (DCP), from the inner nuclear layer (INL) 
to the outer plexiform layer (OPL); and the outer retina, from the outer nuclear layer (ONL) to 
the RPE. Data from the foveal avascular zone (FAZ) were excluded similar to those of retinal 
sensitivity. Software provided by Nidek staff enabled measurement of each thickness 
automatically as well as a comparison of the different thicknesses. The relationship between 
retinal sensitivity and retinal thickness also was evaluated. 
Detection of ME and MAs 
ME was defined as a retinal thickness >350 μm on the OCT color map (Fig. 1h). MAs 
were detected using indirect ophthalmoscopy, fundus photography, OCTA, FA, and ICGA. FA 
was superior to OCTA in detecting MAs as previously reported [6]. Moreover, leaky MAs were 
well detected on ICGA because of less dye leakage (Fig. 1i, j) [11, 12]. Fresh MAs were 
sometimes not detected on ICGA, although the reason was not clear. Therefore, if there was 
disagreement about judgement of MAs, the FA measurement had priority. Two retinal 
specialists (T.T. and Y.H.) who were masked to the retinal sensitivity, determined whether ME 
or MA was observed around each MP-3 measurement point within 3 months from MP-3 
measurement. 
Grouping of the Location of MP-3 Measurement Points in NPAs 
The MP-3 measurement points in NPAs were divided into 3 groups: those in the center 
(zone A), those within 300 μm from the perfused area (zone B), and those near the FAZ (zone 
C) (Fig. 1f). If the point could not be categorized due to the zones overlapping, it was included in 
all of them. Mean retinal sensitivity and frequency of ME or MA formation of the 3 groups were 
compared. 
Treatments 
Intravitreal injections of the anti-VEGF agents, ranibizumab (Lucentis, Novartis, Bülach, 
Switzerland) for eyes with BRVO and aflibercept (Eylea, Bayer, Berlin, Germany) for eyes with 
CRVO, were used to treat ME after RVO. Patients who did not want anti-VEGF therapy because 
of the cost or previous cerebral and/or cardiovascular events received sub-Tenon’s capsule 
injection of triamcinolone acetonide (Kenacort, Bristol-Myers, Tokyo, Japan). Additional 
injections were applied for recurrent or residual ME when the central retinal thickness exceeded 
250 μm. Scatter laser photocoagulation was performed for retinal neovascularization and/or 
NPAs >5 disk diameters for eyes with BRVO and >10 disk areas for eyes with CRVO. 
Statistical Analysis 
VA was measured using Landolt C charts and converted to a logarithm of the minimal 
angle of resolution (logMAR) for statistical analyses. Spearman’s rank correlation coefficient 
was used to evaluate a correlation between retinal sensitivity and VA, duration after disease 
onset, and retinal thickness. Unpaired t test was used to compare retinal sensitivity with and 
without ME or MAs. Post hoc Bonferroni correction was used to compare retinal sensitivity. 
Multivariate regression analysis was performed to detect factors correlative of retinal sensitivity. 
Independent χ2 test was used to compare the presence of ME and MA formation. p < 0.05 was 
considered statistically significant. 
Results 
Patient Characteristics and Retinal Sensitivity 
Sixty eyes of 30 patients (15 men and 15 women) were enrolled, including 27 eyes with 
BRVO, 3 with CRVO, and 30 fellow eyes. The patient characteristics are shown in Table 1. 
Of the 990 MP-3 measurement points (30 RVO eyes × 33 points), 193 were detected in 
the NPAs, 598 in the perfused areas, and 199 in the FAZ, respectively. The mean retinal 
sensitivity values in the fellow eyes, perfused areas, and NPAs of the eyes with RVO were 27.7 
± 4.2, 26.4 ± 5.1, and 17.8 ± 9.4 dB, respectively (Fig. 2a). The retinal sensitivity levels in eyes 
with RVO, even in the perfused areas, were significantly lower than those in the fellow eyes. 
Figure 2b shows the relationship between duration after disease onset and mean retinal 
sensitivity in the NPAs in each RVO eye. The mean retinal sensitivity in the NPAs was 
correlated inversely with duration after disease onset (r = –0.379, p = 0.0391).  
Relationship between Retinal Sensitivity and ME or MA 
Figure 2c, d show the retinal sensitivity with and without ME or MA around the MP-3 
measurement points. The mean retinal sensitivity of points where ME was observed was 
significantly (p < 0.0001) higher than that of the other points. Similarly, the mean retinal 
sensitivity around the MAs was significantly (p < 0.0001) higher than those of the other points. 
Taken together, the retinal sensitivity was correlated positively with ME and MA formation. 
Relationship between Retinal Sensitivity and Retinal Thickness 
Figure 3 shows the relationship between retinal sensitivity and each layer thickness. 
Figure 3a is a schema of each retinal layer. All mean thicknesses, i.e., of the whole retina, SCP, 
DCP, and outer retina, in the NPAs were thinner than in the perfused areas and the fellow eyes 
(Fig. 3b–e). The retinal sensitivity was correlated significantly and positively with the thicknesses 
of the entire retina (r = 0.24770, p = 0.0034**; Fig. 3f), the DCP (r = 0.1744, p = 0.0400*; Fig. 
3h), and the outer retina (r = 0.2937, p = 0.0004**; Fig. 3i), but not with that of the SCP (r = 
0.1513, p = 0.0753; Fig. 3g). Multivariate analysis revealed that both the DCP and outer retinal 
thicknesses were associated with retinal sensitivity (Table 2). 
Relationship between Location in NPAs and Retinal Sensitivity, ME, and MA 
Figure 4 shows the mean retinal sensitivity in each group. The mean retinal sensitivity in 
zone B was significantly higher than in zone A (p = 0.0013) and zone C (p = 0.0277) (Fig. 4a). 
MAs were observed significantly more frequently in zone B (p < 0.0001**) (Fig. 4b) but ME was 
not (p = 0.115) (Fig. 4c). 
Discussion 
First, we found the mean retinal sensitivity in the perfused areas and NPAs were 
significantly lower than in the fellow eyes, possibly because the VA in the eyes with RVO 
decreased. We also found an inverse correlation between the mean retinal sensitivity in the 
NPAs and duration after disease onset, suggesting that the function of old NPAs might have 
deteriorated. 
Second, we found that all of the SCP, DCP, and outer retina in the NPAs were thinner 
than those in the perfused areas and the fellow eyes. RVO usually causes inner retinal ischemia 
followed by an inner retinal thinning. In fact, a thinning of the ganglion cell complex has been 
reported in eyes with BRVO [13], consistent with our results. Furthermore, we found that the 
thicknesses of the DCP and outer retina were correlated with the retinal sensitivity. Kadomoto et 
al. [8] recently reported that parafoveal NPA size was more associated with the macular 
sensitivity than ellipsoid zone (EZ) integrity in eyes without ME after BRVO. However, they 
defined macular sensitivity as mean value from a total 29 points in the central 6° area and the 
EZ integrity as defect length of vertical EZ band through the center of the fovea. Therefore, the 
influence of the unaffected area was not eliminated. In our study, NPAs were examined apart 
from the perfused areas and each point in the NPA was also independently examined. A 
previous report [14] showed that the EZ integrity affected visual function in BRVO, so the 
thickness of outer retina also might affect the retinal sensitivity.  
We also found that the retinal sensitivity in the areas where ME and MAs were not 
observed was significantly lower than in the other areas. VEGF levels were upregulated in eyes 
with RVO [1, 2], leading to ME [3] or MA formation [4, 15]. Previous studies have also reported 
that anti-VEGF therapy could reduce ME [16, 17] and MA formation [4] in patients with RVO, 
suggesting that VEGF levels are related closely to ME and MA formation. VEGF-A affects 
neuronal growth, differentiation, and survival [18]. In addition, the receptors for VEGF-A were 
present in normal retinal neuron cells in animal models, especially in the DCP [19, 20]. 
Therefore, when the DCP is intact, VEGF expression might be upregulated in the condition of 
hypoxia such as RVO, leading to ME or MA formation. 
The Branch Vein Occlusion Study Group (BVOS) established laser photocoagulation as 
the gold standard for treating ME associated with BRVO before the introduction of anti-VEGF 
therapy [21]. Tomomatsu et al. [22] reported that laser photocoagulation for peripheral NPAs 
prevented the recurrence of ME in BRVO. However, Campochiaro et al. [23] reported that 
scatter photocoagulation did not reduce macular edema in BRVO. Retinal sensitivity in the 
NPAs was not examined in these reports. Our results showed that, if the area in the NPAs 
where the retinal sensitivity decreased did not cause ME, laser photocoagulation applied to 
reduce ME might be fruitless. 
We then found that the retinal sensitivity of points in zone B was significantly higher than 
in the other zones. We also showed an inverse correlation between the mean retinal sensitivity 
in the NPAs and the duration after disease onset. Taken together, the NPA at the border might 
be relatively fresh and the retinal sensitivity remains compared with that in the center of the 
NPAs. In the natural course of RVO, NPAs progress due to upregulation of VEGF [24]. We 
speculate that the NPA might spread gradually from the edge due to upregulation of VEGF. We 
found that MAs were detected significantly and more frequently in zone B, where the retinal 
sensitivity remained. MAs have been detected frequently at the edges of NPAs in eyes with 
RVO, consistent with the hypothesis that they are a secondary reaction to hypoxia and 
increased local VEGF concentration [25], which confirms our results. 
Regarding the location of ME, we found no significant difference across the 3 zones, i.e., 
zones B and C were more common locations of ME than zone A. ME is usually observed at the 
center of the macula because there are no venules that drain back the extravascular fluid [25]. 
Therefore, the incidence of ME in zone C might be comparable to that in zone B. 
Our study had several limitations. First, the sample size was small and the study design 
was retrospective. Second, the captured area was too small. Third, the patients received 
different treatments. Fourth, the VEGF levels in the vitreous humor of each patient should be 
measured.  
In conclusion, our results showed that both the inner and outer retina became thinner and 
the retinal sensitivity decreased in NPAs in eyes with RVO. Both DCP and outer retinal 
thickness were correlated with retinal sensitivity. Furthermore, ME or MA was unlikely to be 
formed in severe retinal ischemic lesions. A future prospective, randomized, controlled study 
with larger samples is needed to confirm these results. 
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Legend(s) 
Fig. 1. A multimodal imaging from an eye with branch retinal vein occlusion (BRVO). a Fundus-
monitoring microperimetry (MP-3). The retinal sensitivity was evaluated at 33 stimulus 
points covering the central 5°. b A magnified image within the central 5° of a. c–e Optical 
coherence tomography angiograms (OCTAs) (3 × 3 mm) centered on the fovea. c Retinal 
superficial capillary plexus. d Retinal deep capillary plexus. e A merged image of the 
entire retina from the internal limiting membrane to the retinal pigment epithelium. f 
Inverted colors of the OCTA image with black on white. Red frame, nonperfused areas 
(NPAs); white lines, points in the center of the NPAs (zone A); yellow lines, points at the 
border between the NPAs and perfused area (zone B); blue lines, points near the foveal 
avascular zone (zone C). g A superimposed image of the MP-3 and OCTA. The MP-3 
measurement points in the NPAs were divided into the abovementioned 3 groups (white, 
yellow, and blue circles. h OCT color map. Red area indicates macular edema. i A 
fluorescein angiogram. j An indocyanine green angiogram. Hyperfluorescent spots 
(arrows) indicated microaneurysms. 
Fig. 2. Retinal sensitivity in the nonperfused areas (NPAs) and the relationship with macular 
edema (ME) or microaneurysm (MA). a Mean retinal sensitivity levels in eyes with retinal 
vein occlusion (RVO), even in the perfused areas, were significantly (** p < 0.0001) lower 
than in the fellow eyes. Data in foveal avascular zone were excluded. b Relationship 
between mean retinal sensitivity in NPAs in each RVO eye and the duration after disease 
onset. There was an inverse correlation between the retinal sensitivity and the time after 
disease onset. The retinal sensitivity with (+) and without (–) ME (c) and MA (d) around 
the microperimetry measurement points. The retinal sensitivity at the points with ME or 
MA (** p < 0.0001) are significantly higher than at those without ME or MA. Error bars 
represent standard deviations. 
Fig. 3.  The relationship between retinal sensitivity and retinal thickness. a Schema of the 
human retina. SCP, superficial capillary plexus; DCP, deep capillary plexus; ILM, internal 
limiting membrane; NFL, nerve fiber layer; GCL, ganglion cell layer; IPL, inner plexiform 
layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; PR, 
photoreceptor; RPE, retinal pigment epithelium. b–e The thickness of each layer was 
measured in fellow eyes and eyes with retinal vein occlusion (RVO), i.e., that of the entire 
retina, from the ILM to the RPE (b); the retinal SCP, from the ILM to the IPL (c); the 
retinal DCP, from the INL to the OPL (d); and the outer retina, from the ONL to the RPE 
(e). All retinal layers in NPAs were thinner than in perfused areas. f–i The relationship 
between retinal sensitivity and retinal thickness of each layer. f The entire retinal 
thickness is correlated significantly and positively with the retinal sensitivity. In particular, 
the DCP thickness (h) and outer retinal thickness (i) are correlated significantly with the 
retinal sensitivity but the SCP thickness (g) is not.  
Fig. 4. The relationship between location in the nonperfused areas and retinal sensitivity, 
macular edema (ME), and microaneurysm (MA). a Mean retinal sensitivity in zones A–C. 
In zone B, it was significantly higher than in the other groups (** p = 0.0013 vs. zone A; 
* p = 0.0277 vs. zone C). b, c The relationship between the location and ME (b) or MA 
(c). MAs were significantly more frequently observed in zone B, but this was not the case 





Table 1. Patient characteristics 
    Age, years 68.3±9.1 
Male/female 15/15 





 CRVO, CRVO/hemi-CRVO 1/2 eyes 
Ischemic/nonischemic 13/17 eyes 
Diabetes mellitus, yes/no/unknown 3/25/2 
Hypertension, yes/no/unknown 13/15/2 
Lens status, phakic/pseudophakic 23/7 eyes 
logMAR VA 0.032±0.24 
CRT, µm 287±52 
Axial length, mm 23.6±1.3 













Direct PHC alone 4 eyes 
Scatter PHC alone 3 eyes 
Both 4 eyes 
      Values appear as mean ± standard deviation or n, unless 
otherwise indicated. BRVO, branch retinal vein occlusion; 
CRVO, central retinal vein occlusion; logMAR, logarithm of the 
minimal angle of resolution; VA, visual acuity; CRT, central 
retinal thickness; MP-3, microperimetry-3; FA, fluorescein 
angiography, ICGA, indocyanine green angiography, VEGF, 
vascular endothelial growth factor; PHC, photocoagulation. 
   
 
 
Table 2. Multivariate regression analysis to detect factors correlative of the retinal sensitivity 
      Factor β p value 
      Superficial capillary plexus thickness 0.1362 0.1171 
Deep capillary plexus thickness 0.3107 0.0007** 
Outer retinal thickness 0.3482 0.0001** 
      ** significant difference. 
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